FDA inspection
Stason Pharmaceuticals, Inc.: FDA inspection ending Oct 25, 2019
FDA inspection 1109969 · Official Action Indicated (OAI) · Irvine, CA
Key facts
| Inspection ID | 1109969 |
|---|---|
| Firm | Stason Pharmaceuticals, Inc. |
| FEI number | 1000160561 |
| Address | 11 Morgan |
| City | Irvine |
| State | CA |
| ZIP | 92618 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Oct 25, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 604889 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data